Suchergebnisse - "TaŞtekİn, Dİdem"

PubPharm (88)

1

Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients : A retrospective study

enthalten in: Medicine | 2024

von Demirci, N. | Azizy, A. | Paksoy, N. | +4

2

Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer

enthalten in: Pathology, research and practice | 2024

von Karabulut, S. | Şen, S. | Soydinç, H. | +5

3

The prognostic factors in patients with advanced hepatocellular carcinoma : impact of treatment sequencing

enthalten in: Journal of chemotherapy (Florence, Italy) | 2024

von Köstek, O. | Demirel, A. | Hacıoğlu, M. | +44

4

Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis : A real-world data from Turkey

enthalten in: Journal of cancer research and therapeutics | 2024

von Karabulut, S. | Afsar, C. | Khanmammadov, N. | +5

5

Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma?

enthalten in: Journal of cancer research and therapeutics | 2024

von Karabulut, S. | Afsar, C. | Paksoy, N. | +3

6

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors : Data From the Turkish Oncology Group

enthalten in: The oncologist | 2023

von Ünal, �. | Azizy, A. | Karabulut, S. | +61

7

Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer : Istanbul R-02 phase II randomized study

enthalten in: Oncology research | 2023

von Senyurek, S. | Saglam, S. | Saglam, E. | +11

8

Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer : A single-center experience

enthalten in: Journal of cancer research and therapeutics | 2023

von Tastekin, D. | Paksoy, N. | Dogan, I. | +4

9

Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer

enthalten in: Journal of cancer research and therapeutics | 2023

von Dogan, I. | Gurbuz, M. | Aydin, E. | +3

10

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer : Real-life data from Turkish oncology group

enthalten in: Journal of cancer research and therapeutics | 2022

von Erol, C. | Sendur Mehmet, A. | Bilgetekin, I. | +48

1
2
3
4
5
6
7
8
9
Nächster »
[9]